Developing

Serum Institute, Bharat Biotech Get DCGI Approval

Two vaccines for coronavirus, Oxford Institute’s Covishield, which is being developed by the Pune-based Serum Institute, and Bharat Biotech’s Covaxin, received emergency approval from the country’s drug regulator today. “We’ll never approve anything if there is slightest of safety concern. The vaccines are 110 per cent safe,” Drug Controller General of India VG Somani said, adding Covishield was found to be 70.42 per cent effective and Bharat Biotech’s Covaxin was “safe and provides a robust immune response”. Hailing the scientific community and frontline Corona warriors, Prime Minister Narendra Modi tweeted, “It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India”. There is no word yet on when the vaccination process will begin. “We’ll never approve anything if there is slightest of safety concern. The vaccines are 110 per cent safe. Some side effects like mild fever, pain and allergy are common for every vaccine,” Drug Controller General of India VG Somani said. The approval from the Drug Controller comes days after a government-appointed experts’ panel gave clearance to the vaccines.   

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top